CINECA IRIS Institutional Research Information System

STASI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.479
SA - Sud America 1.194
NA - Nord America 886
EU - Europa 541
AF - Africa 51
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.154
Salva come PNG Salva come JPEG
Nazione #
VN - Vietnam 1.060
BR - Brasile 921
US - Stati Uniti d'America 784
HK - Hong Kong 703
SG - Singapore 692
KR - Corea 316
CN - Cina 301
IT - Italia 278
BD - Bangladesh 262
AR - Argentina 108
FR - Francia 80
DE - Germania 57
MX - Messico 52
ID - Indonesia 51
EC - Ecuador 50
CO - Colombia 29
GB - Regno Unito 29
RU - Federazione Russa 28
CL - Cile 27
CA - Canada 26
PY - Paraguay 19
ZA - Sudafrica 19
IN - India 18
NL - Olanda 17
PE - Perù 16
IQ - Iraq 15
VE - Venezuela 15
PL - Polonia 14
UA - Ucraina 14
AZ - Azerbaigian 9
EG - Egitto 9
MA - Marocco 8
PK - Pakistan 8
UZ - Uzbekistan 8
UY - Uruguay 7
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 4
ES - Italia 4
FI - Finlandia 4
HN - Honduras 4
KE - Kenya 4
LB - Libano 4
TR - Turchia 4
AM - Armenia 3
CR - Costa Rica 3
HU - Ungheria 3
JP - Giappone 3
KZ - Kazakistan 3
MY - Malesia 3
PR - Porto Rico 3
SN - Senegal 3
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
DZ - Algeria 2
GT - Guatemala 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
LT - Lituania 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.154
Salva come PNG Salva come JPEG
Città #
Hong Kong 703
Ho Chi Minh City 432
Seoul 315
Singapore 258
Hanoi 239
San Jose 160
Ashburn 128
Chicago 128
São Paulo 78
Beijing 58
New York 55
Dallas 46
Florence 44
Haiphong 39
Rome 37
Rio de Janeiro 36
Da Nang 32
Biên Hòa 30
Mexico City 30
Los Angeles 26
Curitiba 25
Munich 24
Hải Dương 20
Bắc Giang 18
Lauterbourg 18
Bắc Ninh 17
Guayaquil 16
Brasília 15
Düsseldorf 15
Frankfurt am Main 15
Hillsboro 15
Milan 14
Goiânia 13
Phủ Lý 13
Porto Alegre 13
Buffalo 12
Hưng Yên 12
Lima 12
Ninh Bình 12
Quito 12
Belo Horizonte 11
Bình Dương 11
Jakarta 11
Naples 11
Orem 11
Thái Bình 11
Toronto 11
Campinas 10
Asunción 9
Baku 9
Guarulhos 9
Hòa Bình 9
Ribeirão Preto 9
Santa Clara 9
Can Tho 8
Ha Long 8
Santiago 8
Caracas 7
Johannesburg 7
Medellín 7
Osasco 7
Tashkent 7
Thái Nguyên 7
Bari 6
Buenos Aires 6
Dhaka 6
Duque de Caxias 6
Huế 6
Phoenix 6
Portsmouth 6
Recife 6
Sorocaba 6
São Gonçalo 6
Taboão da Serra 6
Turin 6
Wroclaw 6
Araçatuba 5
Bauru 5
Betim 5
Bexley 5
Cachoeirinha 5
Canoas 5
Caxias do Sul 5
Joinville 5
Long An 5
Mauá 5
Montevideo 5
Petrópolis 5
Resistencia 5
Rio Grande 5
Salvador 5
Suzano 5
São Bernardo do Campo 5
Thủ Đức 5
Vila Velha 5
Volta Redonda 5
Warsaw 5
Barra Mansa 4
Beirut 4
Belém 4
Totale 3.587
Salva come PNG Salva come JPEG
Nome #
Recensione del libro di M.D. Gershon. Il secondo cervello. UTET- Torino 2005 104
The Epidemiology of Chronic Hepatitis C: Where We Are Now 90
Evaluation of latent links between irritable bowel syndrome and sleep quality 75
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model 71
Morbidity risk in an Italian cohort of HBV and HCV patients. 66
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 65
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play? 64
Sexual Behavior and Awareness of Sexually Transmitted Diseases among Street-Based Female Sex Workers in the Florence Area, Central Italy 62
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 60
Hepatitis C Virus Opportunistic Screening in South-Eastern Tuscany Residents Admitted to the University Hospital in Siena 60
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic 58
Prevalence and features of chronic viral hepatitis and HIV/viral hepatitis coinfections in Italian prisons 57
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany. 57
Evaluation of serotonin transporter in patients with irritable bowel syndrome both before and after treatment with alosetron 57
COVID-19’s Impact on psychological disorders, gastrointestinal and liver diseases 57
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 57
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 56
Early Warning Approach to Identify Positive Cases of SARS-CoV-2 in School Settings in Italy 54
Hepatitis B virus screening and accelerated vaccination program in prison: A multicentre pilot study 52
Assessment of liver fibrosis stage in PBC 52
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 52
Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin 52
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness 51
Emerging trends in epidemiology of hepatitis b virus infection 50
Assessment of Free Light Chains in HCV positive patients undergoing Rituximab treatment. 50
Bimodal rehabilitation of the pelvic floor dyssynergia: fact or fiction? 50
Assessment of liver stiffness in patients with HCV-related mixed cryoglobulinemia undergoing rituximab treatment 49
Correlation between indirect serum markers and morphometric values of fibrotic tissue in PBC 49
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis 48
The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes 48
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome 48
Genetic and B-cell clonality markers in HCV-related cryoglobulinemic vasculitis persisting after DAA therapy 47
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 47
Evolving strategies for liver fibrosis staging: Non-invasive assessment 47
DRESS syndrome in a patient with chronic hepatic encephalopathy 47
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis 46
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease 46
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 46
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 46
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment 46
LA SALUTE DEI DETENUTI IN ITALIA: i risultati di uno studio multicentrico 45
Post-COVID-19 Pandemic Sequelae in Liver Diseases 45
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP). 45
Epidemiologia dell’infezione cronica da HCV in Toscana. Rapporto, Luglio, 2017 45
Crohn’s disease and psychological disorders 44
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 44
Prevalenza e caratteristiche delle epatiti virali croniche e di altre malattie infettive nelle strutture detentive in Italia 44
Viral kinetics in patients with chronic hepatitis B treated with combination therapy with PEG-IFN and nucleoside analogues 44
Increased levels of neuropeptide Y in patients with irritable bowel sindrome 44
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 43
Acute viral hepatitis increases liver stiffness values measured by transient elastography 43
Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry 43
Malattie Infettive 43
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients. 42
Prevalenza delle epatiti virali croniche e della sindrome da immunodeficienza acquisita in una coorte urbana in Toscana (Italy). 42
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 42
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 42
Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals 42
An extended assessment of bowel habits in a general population 42
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 41
Radionuclide gastroesophageal motor studies 41
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis 41
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders 41
The relationship between the serotonin metabolism, gut-microbiota and the gut-brain axis 41
Evaluation of latent links between irritable bowel syndrome and sleep quality 41
Il modello della pelle biologica per la costruzione della identità psichica 40
Prevalenza e caratteristiche dei pazienti HIV con coinfezioni da virus delle epatiti croniche B e C in Toscana 40
IBS clinical management in Italy: The AIGO survey 40
Malattie infiammatorie croniche intestinali. Il morbo di Crohn nel modello psiconeuroendocrinologico. 40
Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination 40
Epatite acuta a eziologia sconosciuta in età pediatrica 39
Could lactoferrin and probiotics improve Helicobacter Pylori eradication rate and reduce side effects of triple standard therapy? 39
Epatiti virali 39
Psiconeuroimmunoendocrinologia nel morbo di Crohn 38
La salute mentale della popolazione detenuta: la situazione italiana emersa da uno studio multicentrico 38
Uncoupling of the hypothalamic-pituitary-adrenal and hypothalamic-autonomic nervous system axes in irritable bowel syndrome 38
Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data 38
Opportunistic screening for Hepatitis C Virus infection among hospitalized patients at the University Hospital in Siena 38
An attempt to define the aetiology of liver cirrhosis mortality in Tuscany 38
Self-perceived normality in defecation habits 38
Longitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment 38
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 38
Gastrointestinal manifestations in myotonic muscular dystrophy 37
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 37
La Rettocolite Ulcerosa nel concetto di Somatopsicosi 36
Infectious diseases in the Tuscan detention setting: Data from the Health Agency of Tuscany 36
The epidemiological changes of HCV and HBV infection in the era of the new antiviral therapy and anti-HBV vaccine 36
Irritable bowel syndrome and chronic constipation: Fact and fiction 36
Il calcolo della prevalenza dell'epatite cronica C attraverso i dati amministrativi: il tentativo toscano 36
Epidemiology of liver cirrhosis 36
SARS-CoV-2 was already circulating in Italy, in early December 2019 35
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 35
The general practitioner's approach to irritable bowel syndrome: from intention to practice 35
Treatment for COVID-19: An overview 35
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 35
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 35
Iperidrosi nel rapporto corpo-mente-corpo 34
The New Era for Liver Fibrosis: The Non Invasive Assessment in Hepatitis C Virus Infected Patients 34
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 34
Health conditions of inmates in Italy 34
Totale 4.604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.891 0 0 0 0 0 0 0 0 130 1.392 318 51
2025/20264.471 321 185 855 1.079 346 49 54 302 410 262 386 222
Totale 6.362